Bicycle Therapeutics plc

BCYC

3 Followers
$8.34 +1.96% $0.16
Follow
5 August
Upcoming Earnings
 
Market Cap.
 
P/E
Overview Metrics Financials
Loading...

BCYC Fair Price

$86.55
Undervalued by 81.8%
To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

Bicycle Therapeutics (BCYC) is a biotechnology company based in the United Kingdom that focuses on developing novel therapeutics based on bicycle peptide technology. This technology enables the creation of small, stable, and highly specific therapeutics with the potential to treat various diseases, including cancer and immune-related disorders. Bicycle Therapeutics is dedicated to developing drugs based on its bicycle peptide platform and building partnership agreements with pharmaceutical companies.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade